Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 10, 2011, Pages 2439-2443

  Helal, Imed ^a   Reed, Berenice ^a   Mcfann, Kim ^a   Yan, Xiang Dong ^a   Fick Brosnahan, Godela M ^a   Cadnapaphornchai, Melissa ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; HUMAN; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SEX DIFFERENCE; URINALYSIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COLORADO; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LONGITUDINAL STUDIES; MALE; ORGAN SIZE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; TIME FACTORS;

EID: 80053893125     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01010211     Document Type: Article

References (37)

1. Iglesias C, Torres V, Offord K, Holley K, Beard C, Kurland L: Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 2: 630-639, 1983
2. U.S. Renal Data System, USRDS 1997 Annual Data Report: Patient Mortality and Survival. Ann Arbor, University of Michigan
3. Pretorius DH, Lee ME, Manco-Johnson ML, Weingast GR, Sedman AB, Gabow PA: Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant. J Ultrasound Med 6: 249-255, 1987
4. MacDermot KD, Saggar-Malik AK, Economides DL, Jeffery S: Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease. J Med Genet 35: 13-16, 1998
5. Ecder T, Fick-Brosnahan GM, Schrier RW: Polycystic kidney disease. In: Diseases of the Kidney and Urinary Tract, 8th ed., edited by Schrier RW, Philadelphia, Lippincott Williams & Wilkins, 2007, pp 502-539
6. Walz G: Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): Is there light at the end of the tunnel? Nephrol Dial Transplant 21: 1752-1757, 2006
7. Grantham JJ, Chapman AB, Torres VE: Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes. Clin J Am Soc Nephrol 1: 148-157, 2006
8. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D: Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20: 205-212, 2009
9. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 2: 259-263, 1976
10. Huang SH, Sharma AP, Yasin A, Lindsay RM, Clark WF, Filler G: Hyperfiltration affects accuracy of creatinine eGFR measurement. Clin J Am Soc Nephrol 6: 274-280, 2011
11. Berg UB, Bäck R, Celsi G, Halling SE, Homberg I, Krmar RT, Monemi KÅ, Oborn H, Herthelius M: Comparison of plasma clearance of iohexol and urinary clearance of inulin for measurement of GFR in children. Am J Kidney Dis 57: 55-61, 2011
12. Chiarelli F, Verrotti A, Morgese G: Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol 9: 154-158, 1995
13. Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW: Prospective change in renal volume and function in children with ADPKD. Clin J Am Soc Nephrol 4: 820-829, 2009
14. Shamshirsaz A, Bekheirnia MR, Kamgar M, Johnson AM, McFann K, Cadapaphornchai M, Nobakht N, Schrier RW: Autosomal dominant polycystic kidney disease I infancy and childhood: Progression and outcome. Kidney Int 68: 2218-2224, 2005
15. Kaariainen H: Polycystic kidney disease in children: A genetic and epidemiological study of 82 Finnish patients. J Med Genet 24: 474-481, 1987
16. Bergmann C, Zerres K: Early manifestations of polycystic kidney disease. Lancet 369: 2157, 2007
17. Bennett WM: Autosomal dominant polycystic kidney disease: 2009 update for internists. Korean J Intern Med 24: 165-168, 2009
18. Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41: 1311-1319, 1992
19. Johnson AM, Gabow PA: Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 8: 1560-1567, 1997
20. Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, Jungers P: Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6: 1634-1642, 1995
21. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5: 1349-1354, 1994
22. Franz KA, Reubi FC: Rate of functional deterioration in polycystic kidney disease. Kidney Int 23: 526-529, 1983
23. Dalgaard OZ: Bilateral polycystic disease of the kidneys: A follow-up of 284 patients and their families. Dan Med Bull 4: 128-133, 1957
24. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort: Renal structure in early autosomal- dominant polycystic kidney disease (ADPKD): The consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int 64: 1035-1045, 2003
25. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP; CRISP Investigators: Volume progression in polycystic kidney disease. N Engl J Med 354: 2122-2130, 2006
26. Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW: Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study. Am J Kidney Dis 39: 1127-1134, 2002
27. Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA: Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int 59: 1654-1662, 2001
28. King BF, Reed JE, Bergstralh EJ, Sheedy PF 2nd, Torres VE: Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11: 1505-1511, 2000
29. Dimitrakov D, Kumchev E, Lyutakova E, Grigorov L: Glomerular hyperfiltration and serum beta 2-microglobulin used as early markers in diagnosis of autosomal dominant polycystic kidney disease. Folia Med (Plovdiv) 35: 59-62, 1993
30. Wong H, Vivian L, Weiler G, Filler G: Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 43: 624-628, 2004
31. Meijer E, Rook M, Tent H, Navis G, van der Jagt EJ, de Jong PE, Gansevoort RT: Early renal abnormalities in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 5: 1091-1098, 2010
32. Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ: The clinical significance of hyperfiltration in diabetes. Diabetologia 53: 2093-2104, 2010
33. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG: Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52: 691-697, 2009
34. Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, Scheffel H, Weishaupt D, Wü thrich RP: Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 363: 820-829, 2010
35. Walz G, Budde K, Mannaa M, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hörl WH, Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Büchert M, May C, Gschaidmeier H, Kramer S, Eckardt KU: Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 363: 830-840, 2010
36. Schrier RW: Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 20: 1888-1893, 2009
37. Torres VE, Harris PC: Mechanisms of disease: Autosomal dominant and recessive polycystic kidney diseases. Nat Clin Pract Nephrol 2: 40-55, 2006